In the latest edition of Nature, Technology Editor,Nathan Blow, PhD, published a Technology Feature on how Next Generation Sequencing is changing gene-expression profiling from analog to digital methods.
Our Director of Scientific Solutions, Dr. Roald Forsberg, was interviewed for the article and shares the vision behind our focus within Gene Expression Analysis - both digital and analog.
I recommend reading the feature, which is really thorough in describing the change from analog to digital gene-expression. You can read it here: Transcriptomics: The digital generation
Recently our Director of Scientific Solutions - and Editor-in-Chief of this blog - Dr. Roald Forsberg, did an online presentation called Comprehensive, Fast, and User-Friendly Downstream Analysis of Illumina Sequencing Data, through Illumina’s webinar series. The presentation was very successful and is now available for everyone, so you can view it her and download the presentation slides. Enjoy!
According to a recent press release, Illumina expects to increase their Genome Analyzer sequencing throughput per run by about 6 times in 2009 - following a 15 fold increase in 2008 this gives them a whopping 90 fold increase in just two years.
Costs are decreasing as throughput is increasing, and a 25x coverage of a human genome is expected to cost only 10,000 USD at the end of 2009, according to Illumina.
The other day I wrote about Oxford Nanopore and their new collaboration with Illumina. The nanopore sequencing technology is truly fascinating with its flurophore-free approach. Thanks to the Aminopop blog I picked up this cool animation of the technology that Oxford Nanopore has produced - enjoy!
Today, a press release announced a today announced a strategic alliance including a commercialization agreement and equity investment. Illumina will market, sell, distribute, and service BASE™ Technology products developed by Oxford Nanopore for DNA sequencing into the research and diagnostic markets on a worldwide basis.
Given Illuminas position in the market, this is a big leap forward for the commerzialization of nanopore sequencing.
